Previously, in patients with neuroblastoma, a study showed that high expressions of TRKA or TRKC in the tumor had no influence on the quality of the prognosis, whereas poor prognosis was observed when high expressions of TRKB and/or BDNF occurred [29], which is consistent with our results. Here, NTRK3 is linked to neoplasm.